Conéctate
Conéctate
O Conectarse con
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Regístrate
O Conectarse con
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

ZAI LAB LIMITED

(ZLAB)
  Reporte
ResumenCotizacionesGráficosNoticiasRatingsAgendaEmpresaFinanzasConsensoRevisionesDerivadosFondos 
ResumenTodasRecomendaciones analistasOtros idiomasComunicadosPubls. oficialesNoticias del sectorEstrategias MarketScreener
Noticias en otros idiomas sobre ZAI LAB LIMITED
31/01Zai Lab Announces Participation in February Investor Conferences
31/01Zai Lab Announces Participation in February Investor Conferences
30/01Zai Lab Says Chinese Regulator Grants Priority Review to New Drug Application for Sulba..
30/01Zai Lab Announces NDA for Sulbactam-Durlobactam (SUL-DUR) Granted Priority Review by Ch..
30/01Zai Lab Announces NDA for Sulbactam-Durlobactam (SUL-DUR) Granted Priority Review by Ch..
30/01Zai Lab Limited Announces New Drug Application for Sulbactam-Durlobactam (SUL-DUR) Gran..
19/01Two Zai Lab Drugs Added to China's National Reimbursement Drug List
18/01Zai Lab's Qinlock, Nuzyra Added to China's National Reimbursement Drug List; Shares Ris..
18/01Paratek Pharmaceuticals Says Nuzyra Added to China's National Reimbursement Drug List
18/01Zai Lab Limited Announces Executive Appointments
18/01Zai Lab's Qinlock, Nuzyra Listed Among China's National Reimbursement Drugs
18/01Zai Lab Announces Inclusion of QINLOCK® (ripretinib) and NUZYRA® (omadacycline) in Chin..
18/01Zai Lab Announces Inclusion of QINLOCK® (ripretinib) and NUZYRA® (omadacycline) in Chin..
18/01Zai Lab Limited Announces Inclusion of QINLOCK® and NUZYRA® (omadacycline) in China..
09/01Zai Lab Ltd : Change in Directors or Principal Officers, Financial Statements and Exhibits..
09/01Zai Lab Appoints Michel Vounatsos To Its Board of Directors
09/01Zai Lab Appoints Michel Vounatsos To Its Board of Directors
09/01Zai Lab Limited Appoints Michel Vounatsos to the Board of Directors
06/01Tumor Treating Fields Study by Zai Lab’s Partner in Cancer Patients Reaches Prima..
06/01ADR Shares End Mostly Lower; Zai Lab, HSBC Trade Actively
05/01Health Care Edge Lower Amid Drug-Development Hopes -- Health Care Roundup
05/01Zai Lab Ltd : Other Events, Financial Statements and Exhibits (form 8-K)
05/01Sector Update: Health Care Stocks Nudge Above Thursday Intra-Day Lows
05/01Sector Update: Health Care Stocks Struggling Thursday but Biotech Edging H..
05/01Top Midday Gainers
05/01Financial Stocks Weigh Down Asian Equities in Thursday Trading
05/01NovoCure, Zai Lab Study in Non-Small Cell Lung Cancer Meets Primary Endpoint'; Shares C..
05/01NovoCure, Zai Lab Say Study of Non-Small Cell Lung Cancer Treatment Meets Primary Endpo..
05/01Zai Lab and Novocure Announce Pivotal LUNAR Study in Non-Small Cell Lung Cancer Met Pri..
05/01Zai Lab and Novocure Announce Pivotal LUNAR Study in Non-Small Cell Lung Cancer Met Pri..
05/01Zai Lab Limited and Novocure Announce Pivotal Lunar Study in Non-Small Cell Lung Cancer..
03/01Zai Lab Announces the Appointment of Dr. Rafael G. Amado as President, Head of Global O..
03/01Zai Lab Limited Announces the Appointment of Dr. Rafael G. Amado as President, Head of ..
03/01Zai Lab Grants Share Options, Restricted Share Units
2022Rebounding US stocks Help Boost American Depositary Receipts of Asian Equities
2022Solar Stocks Weigh on Asian Equities in Friday Trading
2022Zai Lab : Statement Regarding the PCAOB's Conclusion That It Has Complete Access to Inspec..
2022Zai Lab Announces Participation in January Investor Conferences
2022Zai Lab Announces Participation in January Investor Conferences
2022Zai Lab Presents Interim Overall Survival Data for ZEJULA® (niraparib) from the NORA Ph..
2022Zai Lab Presents Interim Overall Survival Data for ZEJULA® (niraparib) from the NORA Ph..
2022Zai Lab Limited Presents Interim Overall Survival Data for ZEJULA® from the NORA Phase ..
2022Zai Lab Grants 108,000 American Depositary Shares
2022Insider Sell: Zai Lab
2022Zai Lab Partner Mirati Therapeutics Presents Late-Breaking Results Evaluating Concurren..
2022Zai Lab Partner Mirati Therapeutics Presents Late-Breaking Results Evaluating Concurren..
2022Asian Equities Decline Despite Reports China Will Further Ease COVID Restrictions
2022Zai Lab : to Present Interim Overall Survival Results for ZEJULA® (niraparib) from the Pha..
2022Hopes of Easing COVID Restrictions Boost Asian Equities
2022Asian Equities Diverge From US Markets, Climb in Thursday Trading
2022Zai Lab Grants American Depositary Shares
2022Asian ADRs Surge Higher in Friday Trading as China Eases COVID-19 Restrictions
2022Asian ADRs Soar in Thursday Trading Following US Inflation Data
2022Zai Lab's Q3 Net Loss Widens
2022Zai Lab Reports Wider Q3 Loss, Higher Revenue
2022ZAI LAB LTD Management's Discussion and Analysis of Financial Condition and Results of..
2022Zai Lab Limited Reports Earnings Results for the Third Quarter and Nine Months Ended Se..
2022Earnings Flash (ZLAB) ZAI LAB LIMITED Posts Q3 Revenue $57.5M
2022Zai Lab Announces Third Quarter 2022 Financial Results and Corporate Updates
2022Zai Lab to Present New Oncology Research at 2022 Society for Immunotherapy of Cancer An..
2022Zai Lab Announces the Appointment of Dr. Peter Huang as Chief Scientific Officer
2022Zai Lab Announces the Appointment of Dr. Peter Huang as Chief Scientific Officer
2022Zai Lab Limited Announces the Appointment of Peter Huang as Chief Scientific Officer
2022Asian ADRs Move Slightly Higher in Wednesday Trading
2022Asian ADRs Surge Higher in Tuesday Trading
2022Zai Lab Announces Participation in November Investor Conferences
2022Zai Lab Announces Participation in November Investor Conferences
2022Zai Lab Ltd : Change in Directors or Principal Officers (form 8-K)
2022Asian ADRs Move Lower in Friday Trading
2022Asian ADRs Move Lower in Thursday Trading
2022Asian ADRs Move Higher in Tuesday Trading
2022Asian ADRs Tumble in Monday Trading
2022Asian ADRs Move Lower in Friday Trading
2022Asian ADRs Move Lower in Tuesday Trading
2022Zai Lab to Announce Third Quarter 2022 Financial Results on November 9, 2022
2022Zai Lab Launches its first Trust Report
2022Zai Lab Launches its first Trust Report
2022Zai Lab Grants Share Options Under Equity Incentive Scheme
2022Zai Lab's H1 Loss Narrows to $220 Million; Shares Slip 6%
2022Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for ..
2022Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for ..
2022Zai Lab Strikes Licensing Deal with Nasdaq-listed Seagen for Cervical Cancer Drug
2022Zai Lab Signs Exclusive Collaboration, License Agreement With Seagen to Develop, Commer..
2022Zai Lab : Corporate Presentation
2022Zai Lab Ltd : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financ..
2022Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for ..
2022Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for ..
2022Asian ADRs Move Lower in Wednesday Trading
2022Zai Lab to Present Analysis of the Impact of Timing for ZEJULA® (niraparib) Maintenance..
2022Zai Lab to Present Analysis of the Impact of Timing for ZEJULA® (niraparib) Maintenance..
2022Zai Lab to Present Analysis of the Impact of Timing for ZEJULA® Maintenance Treatment i..
2022DRI Healthcare Trust Acquires Royalty Interest in Zejula, Currently Approved for Treatm..
2022Asian ADRs Climb Sharply Higher in Friday Trading
2022US, China Reach Audit Deal to Prevent Delistings
2022Zai Lab : Updated Statement on SEC Listing Matter
2022Zai Lab Announces Participation in September Investor Conferences
2022Zai Lab : Argenx Announces European Commission Approval of VYVGART™ (efgartigimod al..
2022Asian ADRs Move Sharply Higher in Wednesday Trading
2022Zai Lab : Corporate Presentation
2022Zai Lab Narrows Q2 Loss as Revenue Jumps 30%; Shares Slide 6%
Próximo evento sobre ZAI LAB LIMITED